High materiality7/10
Ionis Pharmaceuticals price target lowered to $85 from $95 at Canaccord
Why it may matterVerify against the original reporting
Downside risk suggested by target cut.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord lowers IONS target to $85; current price $58.09.
- Target $85; price $58.09
Key facts
- 01
Target: $85
- 02
Posted price: $58.09
- 03
Analyst firm: Canaccord Genuity
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.